Welcure Drugs

{
  "main_header": {
    "sid": 736142,
    "name": "Welcure Drugs",
    "stock_name": "Welcure Drugs",
    "full_name": "Welcure Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/welcure-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.31",
    "chg": 0.02,
    "chgp": "6.9%",
    "dir": 1,
    "prev_price": "0.29",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524661,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE331C01025",
    "curr_date": "Apr 09",
    "curr_time": "",
    "bse_nse_vol": "51.11 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 09, 2026",
    "traded_date_str": "2026 04 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3939481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_mojoScore_3939481.png",
        "date": "2026-04-09 10:10:18",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 0.23 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-023-3928657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_priceRelatedfactors_3928657.png",
        "date": "2026-04-01 10:02:51",
        "description": "A steep decline has pushed Welcure Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 0.23 on 1 Apr 2026, marking a significant 68.82% drop over the past year despite a broader market that has been relatively resilient."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs024-3902542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3902542.png",
        "date": "2026-03-20 09:41:23",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs025-3899975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3899975.png",
        "date": "2026-03-19 09:58:00",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs026-3894013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3894013.png",
        "date": "2026-03-16 12:44:42",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-amid-market-downturn-3888549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3888549.png",
        "date": "2026-03-13 09:58:45",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3873284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_mojoScore_3873284.png",
        "date": "2026-03-05 10:10:02",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3845619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WelcureDrugsPha_mojoScore_3845619.png",
        "date": "2026-02-18 10:10:25",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3841649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WelcureDrugsPha_valuationdot_3841649.png",
        "date": "2026-02-16 08:03:47",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive valuation grade. This change is underscored by its exceptionally low price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both its historical averages and peer group benchmarks, signalling a potential opportunity for value investors amid a challenging market backdrop."
      }
    ],
    "total": 290,
    "sid": "736142",
    "stock_news_url": "https://www.marketsmojo.com/news/welcure-drugs-pharmaceuticals-736142"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the 4th Quarter and Annual year ended 31st MArch 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation of Closure of Trading Window for the 4th Quarter and Annual Year Ended 31 March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2026",
      "details": "Newspaper Clipping of Unaudited Financials for 3rd Quarter ended December 21 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-09 10:10:18

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 0.23 Amidst Prolonged Downtrend

2026-04-01 10:02:51

A steep decline has pushed Welcure Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 0.23 on 1 Apr 2026, marking a significant 68.82% drop over the past year despite a broader market that has been relatively resilient.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24

2026-03-20 09:41:23

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25

2026-03-19 09:58:00

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26

2026-03-16 12:44:42

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn

2026-03-13 09:58:45

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-03-05 10:10:02

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-02-18 10:10:25

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-02-16 08:03:47

Welcure Drugs & Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive valuation grade. This change is underscored by its exceptionally low price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both its historical averages and peer group benchmarks, signalling a potential opportunity for value investors amid a challenging market backdrop.

Read full news article

View All News